Key stats
About UBS MSCI Switzerland IMI Socially Responsible ETF Units -CHF dis-
Home page
Inception date
Sep 11, 2017
Structure
Swiss CISA
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
UBS Fund Management (Switzerland) AG
ISIN
CH0368190739
The fund generally invests in Swiss large, mid and small cap stocks contained in the MSCI Switzerland IMI Extended SRI 5% Issuer Capped Index. The relative weightings of the companies correspond to their weightings in the index.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Finance
Consumer Non-Durables
Producer Manufacturing
Stocks200.37%
Health Technology32.53%
Finance26.17%
Consumer Non-Durables14.07%
Producer Manufacturing12.72%
Process Industries4.46%
Commercial Services2.77%
Communications2.36%
Electronic Technology2.07%
Transportation1.26%
Consumer Durables0.68%
Distribution Services0.68%
Industrial Services0.17%
Retail Trade0.07%
Bonds, Cash & Other−100.37%
Cash−100.37%
Stock breakdown by region
Europe100.00%
North America0.00%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
CHSRI invests in stocks. The fund's major sectors are Health Technology, with 65.17% stocks, and Finance, with 52.43% of the basket. The assets are mostly located in the Europe region.
CHSRI top holdings are ABB Ltd. and Roche Holding Ltd Dividend Right Cert., occupying 10.52% and 10.45% of the portfolio correspondingly.
CHSRI last dividends amounted to 0.31 CHF. The year before, the issuer paid 0.03 CHF in dividends, which shows a 90.32% increase.
CHSRI assets under management is 257.60 M CHF. It's fallen 5.82% over the last month.
CHSRI fund flows account for −290.03 M CHF (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, CHSRI pays dividends to its holders with the dividend yield of 0.00%. The last dividend (Sep 9, 2025) amounted to 0.34 CHF. The dividends are paid annually.
CHSRI shares are issued by UBS Group AG under the brand UBS. The ETF was launched on Sep 11, 2017, and its management style is Passive.
CHSRI expense ratio is 0.28% meaning you'd have to pay 0.28% of your investment to help manage the fund.
CHSRI follows the MSCI Switzerland IMI Extended SRI Low Carbon Select 5% Issuer Capped Index - CHF. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
CHSRI invests in stocks.
CHSRI price has fallen by −4.08% over the last month, and its yearly performance shows a −0.44% decrease. See more dynamics on CHSRI price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −1.75% over the last month, showed a 0.15% increase in three-month performance and has increased by 1.67% in a year.
NAV returns, another gauge of an ETF dynamics, have fallen by −1.75% over the last month, showed a 0.15% increase in three-month performance and has increased by 1.67% in a year.
CHSRI trades at a premium (0.19%) meaning the ETF is trading at a higher price than the calculated NAV.